Drugs

Get the info you need on this PTH replacement therapy as part of our September drug news roundup.

Get the info you need on this new product as part of our September drug news roundup.

Get the information you need on this new monotherapy as part of our drug news roundup for September.

Check out the info you need on this new drug as part of our full drug news roundup for September.

Get the details on this new product as part of our drug news roundup for September.

Product monographs are being updated to include the risk of serious hypertension, myocardial infarction (MI), stroke and seizures in postpartum women taking cabergoline.

A Health Canada safety review assesses the potential risk of weight loss in children under age six who are prescribed off-label central nervous system stimulants for ADHD.

The clinical trial, published in JAMA Psychiatry Wednesday, found the treatment reduced depressive symptoms for more than 35% of participants, who received two 40-minute ketamine infusions over two weeks.